Market Overview:
The global non-invasive parenteral screening instruments market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for early diagnosis and treatment, and technological advancements in screening instruments. Based on type, the global non-invasive parenteral screening instruments market is segmented into ultrasound devices, next-generation sequencing systems (NGS), polymerase chain reaction (PCR) instruments, microarrays, and others. The ultrasound devices segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to its high accuracy and reliability for diagnosing various diseases such as cancer and heart disorders. Based on application, the global non-invasive parenteral screening instruments market is divided into diagnostic laboratories and hospitals.
Product Definition:
Non-invasive parenteral screening instruments are used to detect the presence of drugs or other substances in a person's body without having to puncture the skin. This type of testing is important because it can help identify people who are using drugs illegally and may be at risk for addiction or other health problems.
Ultrasound Devices:
Ultrasound devices are used for non-invasive parenteral screening of the liver, kidney, and other internal organs. It is a diagnostic tool that creates ultrasound image of the targeted organ or tissue to be screened. Ultrasound imaging helps in identifying diseases & conditions at early stages so as to avoid complications later on.
Next-Generation Sequencing Systems:
Next-generation sequencing (NGS) systems are the most advanced tools available for accurate and rapid DNA sequencing. It is a set of technologies that involve high-throughput genetic analysis in which NGS system plays an important role. This technology has been used extensively in human genome project to determine the sequence of all human genes.
The development and launch of next-generation sequencing instruments have led to significant improvements in throughput, cost reduction, increased sample volume,.
Application Insights:
The diagnostic laboratories segment dominated the global non-invasive parenteral screening instruments market in 2017. This can be attributed to a rising number of cancer cases and increasing government funding for research related to cancer. For instance, according to the American Cancer Society, an estimated 1,715 new cases of pancreatic cancer were reported in 2016 in the U.S., along with 609 deaths due to this disease that year. Thus, such factors are expected to increase demand for NIPSSI over the forecast period thereby driving growth during this period.
On other hand, hospitals are anticipated to register noteworthy CAGR owingto an increasing number of patients suffering from life-threatening conditions requiring immediate hospital admission and surgery within 24 hours (urgent care).
Regional Analysis:
North America dominated the global market in 2017. The presence of sophisticated healthcare infrastructure, high adoption rate of advanced technologies, and increasing demand for diagnostic tests are some factors contributing to the growth of this regional market. Moreover, government initiatives promoting non-invasive prenatal screening and raising awareness about maternal health are expected to drive the demand for NIPS instruments over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and growing target population base in countries such as India & China & Japan. In addition, a rise in research funding by private organizations is likely to fuel innovation leading to development of new products suitable for Asian countries with low cost structure compared with developed nations such as U.S.
Growth Factors:
- Increasing demand for early diagnosis of diseases: The global non-invasive parenteral screening instruments market is expected to grow at a CAGR of 7.5% during the forecast period owing to the increasing demand for early diagnosis of diseases. This is mainly due to the rising incidences of lifestyle-related disorders and chronic diseases such as cancer, diabetes, and heart disease.
- Technological advancements: The development of new technologies in the field of non-invasive parenteral screening instruments is expected to drive market growth during the forecast period. For instance, in 2017, Siemens Healthcare introduced its SECTRA MicroDose CT system that uses low radiation doses for breast cancer detection. This system offers improved image quality and faster scanning times as compared to traditional CT systems, which is likely to boost its adoption among healthcare providers worldwide.
- Growing awareness about preventive health care: There has been a growing awareness among people about preventive health care in recent years owing to changing lifestyles and rising incidences of chronic diseases across the globe. This has led healthcare providers shift their focus towards offering preventive health care services such as non-invasive parenteral screenings instead of relying only on treatment services post diagnosis stage..This is likelyto fuel market growth duringthe forecastperiod .
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-invasive Parenteral Screening Instruments Market Research Report
By Type
Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Others
By Application
Diagnostic Laboratories, Hospitals
By Companies
GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Non-invasive Parenteral Screening Instruments Market Report Segments:
The global Non-invasive Parenteral Screening Instruments market is segmented on the basis of:
Types
Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Laboratories, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Philips
- Illumina
- Thermo Fisher Scientific
- Roche
- PacBio
- Perkinelmer
- Qiagen
- Agilent Technologies
- BGI Group
Highlights of The Non-invasive Parenteral Screening Instruments Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ultrasound Devices
- Next-Generation Sequencing Systems
- Polymerase Chain Reaction Instruments
- Microarrays
- Others
- By Application:
- Diagnostic Laboratories
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-invasive Parenteral Screening Instruments Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-invasive Parenteral Screening Instruments are a type of medical device that can be used to detect certain types of diseases in the body. These devices use small amounts of fluid to test for signs and symptoms of disease, which can help doctors diagnose and treat conditions more quickly.
Some of the major players in the non-invasive parenteral screening instruments market are GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen, Agilent Technologies, BGI Group.
The non-invasive parenteral screening instruments market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-invasive Parenteral Screening Instruments Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-invasive Parenteral Screening Instruments Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-invasive Parenteral Screening Instruments Market - Supply Chain
4.5. Global Non-invasive Parenteral Screening Instruments Market Forecast
4.5.1. Non-invasive Parenteral Screening Instruments Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-invasive Parenteral Screening Instruments Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-invasive Parenteral Screening Instruments Market Absolute $ Opportunity
5. Global Non-invasive Parenteral Screening Instruments Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Type
5.3.1. Ultrasound Devices
5.3.2. Next-Generation Sequencing Systems
5.3.3. Polymerase Chain Reaction Instruments
5.3.4. Microarrays
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-invasive Parenteral Screening Instruments Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Application
6.3.1. Diagnostic Laboratories
6.3.2. Hospitals
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-invasive Parenteral Screening Instruments Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-invasive Parenteral Screening Instruments Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-invasive Parenteral Screening Instruments Demand Share Forecast, 2019-2026
9. North America Non-invasive Parenteral Screening Instruments Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Application
9.4.1. Diagnostic Laboratories
9.4.2. Hospitals
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Type
9.7.1. Ultrasound Devices
9.7.2. Next-Generation Sequencing Systems
9.7.3. Polymerase Chain Reaction Instruments
9.7.4. Microarrays
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-invasive Parenteral Screening Instruments Demand Share Forecast, 2019-2026
10. Latin America Non-invasive Parenteral Screening Instruments Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Application
10.4.1. Diagnostic Laboratories
10.4.2. Hospitals
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Type
10.7.1. Ultrasound Devices
10.7.2. Next-Generation Sequencing Systems
10.7.3. Polymerase Chain Reaction Instruments
10.7.4. Microarrays
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-invasive Parenteral Screening Instruments Demand Share Forecast, 2019-2026
11. Europe Non-invasive Parenteral Screening Instruments Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Application
11.4.1. Diagnostic Laboratories
11.4.2. Hospitals
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-invasive Parenteral Screening Instruments Market Size andVolume Forecast by Type
11.7.1. Ultrasound Devices
11.7.2. Next-Generation Sequencing Systems
11.7.3. Polymerase Chain Reaction Instruments
11.7.4. Microarrays
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-invasive Parenteral Screening Instruments Demand Share, 2019-2026
12. Asia Pacific Non-invasive Parenteral Screening Instruments Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Application
12.4.1. Diagnostic Laboratories
12.4.2. Hospitals
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Type
12.7.1. Ultrasound Devices
12.7.2. Next-Generation Sequencing Systems
12.7.3. Polymerase Chain Reaction Instruments
12.7.4. Microarrays
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-invasive Parenteral Screening Instruments Demand Share, 2019-2026
13. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Application
13.4.1. Diagnostic Laboratories
13.4.2. Hospitals
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-invasive Parenteral Screening Instruments Market Size and Volume Forecast by Type
13.7.1. Ultrasound Devices
13.7.2. Next-Generation Sequencing Systems
13.7.3. Polymerase Chain Reaction Instruments
13.7.4. Microarrays
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-invasive Parenteral Screening Instruments Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-invasive Parenteral Screening Instruments Market: Market Share Analysis
14.2. Non-invasive Parenteral Screening Instruments Distributors and Customers
14.3. Non-invasive Parenteral Screening Instruments Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Philips
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Illumina
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fisher Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. PacBio
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Perkinelmer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Qiagen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Agilent Technologies
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. BGI Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook